FDA 483 - Arizona Reproductive Medicine Specialists - June 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Arizona Reproductive Medicine Specialists in Phoenix, AZ, revealed significant deficiencies in donor eligibility determination and HCT/P handling. The firm failed to adequately test and screen donors for communicable diseases, maintain proper records, and apply required warning labels to reproductive tissues. These issues raise concerns about the safety and quality of the human cells, tissues, and cellular and tissue-based products (HCT/Ps) provided.
ID · c1e1a2ec-845a-4bfe-a80e-087e1209a7d0